Hunter Capital RTO 1 (HCRTO1) | Spotlight

Hunter Capital RTO1 is a company shell to be listed, which will then be used to list another company via a reverse acquisition. The company seeks to acquire one or more companies and associated assets in the financial markets, primarily through mergers, IPOs, acquisitions, share purchases and major reorganizations. Hunter Capital is behind the company.

Quotes for Hunter Capital RTO 1 AB

Right Now

+/-: 0.191
%: 44,52%
Latest: 0.62
High: 0.7
Low: 0.5
Volume: 95 812
Turnover (SEK): 61 313
Market Value (MSEK): 28,2
Time (Latest trade): 2026-04-21 09:37

Board

CEO

Jacob Eriksson

Chairperson of the Board

Oliver Aleksov

Board

Jacob Eriksson
Per Karlsson

News

2026-03-30 10:45:00 Hunter Capital RTO 1 signs Letter of Intent for reverse takeover of Nordic Phase 2 biotech company at an implied valuation of SEK 365–405 million
2026-03-30 10:45:00 Hunter Capital RTO 1 ingår avsiktsförklaring om omvänt förvärv av nordiskt bioteknikbolag i fas 2 till en implicerad värdering om 365–405 MSEK
2026-03-13 20:00:00 Hunter Capital RTO 1 AB (publ) publicerar årsredovisning för 2025
2026-03-04 08:50:00 Hunter Capital RTO 1 AB (publ) erhåller godkännande för notering på Spotlight Stock Market

News agencies

2026-03-30 10:56:11 Finwire: Hunter Capital RTO1 enters into a letter of intent for reverse acquisition of Resother Pharma
2026-03-27 14:50:51 Finwire: Hunter Capital RTO1 clarifies insider transaction (update)
2026-03-27 09:38:56 Finwire: Hunter Capital RTO1"s chairman Oliver Aleksov makes a minor share sale

Insider trading

*Powered by Modular Finance

Key Numbers

*Compiled data from Millistream

Upcoming reports

2026-05-29 Interim Report 2026-Q1
2026-06-30 Annual General Meeting 2025
2026-08-31 Interim Report 2026-Q2
2026-11-27 Interim Report 2026-Q3

Annual reports, prospectus etc.

2026-03-16 Årsredovisning 2025